Aspen Aerogels (ASPN) EBITDA (2013 - 2026)

Aspen Aerogels (ASPN) has reported EBITDA for 14 consecutive years, with -$28.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 458.37% year-over-year to -$28.8 million; the trailing twelve-month figure through Jun 2026 stood at -$123.4 million (up 54.71% YoY), and the FY2025 full-year result was -$378.2 million, down 793.55% from the prior year.
• EBITDA eased to -$28.8 million in Q2 2026 per ASPN's latest filing, from -$20.8 million in the prior quarter.
• Across five years, EBITDA topped out at $20.0 million in Q2 2024 and bottomed at -$299.3 million in Q1 2025.
• Historically, EBITDA has averaged -$27.9 million across 5 years, with a median of -$15.8 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBITDA soared 963.85% in 2024, then slumped 12388.22% in 2025.
• Over 5 years, EBITDA stood at -$9.7 million in 2022, then soared by 114.31% to $1.4 million in 2023, then jumped by 963.85% to $14.7 million in 2024, then sank by 578.38% to -$70.4 million in 2025, then soared by 59.1% to -$28.8 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$28.8 million, -$20.8 million, and -$70.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.